Swine flu, a new strain of influenza, has so far left more than a hundred dead. But in one sector, the illness could have huge benefits.
Swine flu, a new strain of influenza, has so far left more than a hundred dead. But in one sector, the illness could have huge benefits.
Pharmaceutical companies profit grows as a yeast, and the interest in such companies as "Roche" or "GlaxoSmithKline" shares is rising and rising.
Šaltinis:
Reuters
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.